Memory protective effect of indomethacin against electroconvulsive shock-induced retrograde amnesia in rats

Biological Psychiatry

Volumn 51, Issue 9, 2002, Pages 770-773

  Rao, Sanjay Kumar ^a   Andrade, Chittaranjan ^b   Reddy, Kishore ^b   Madappa, K N ^b   Thyagarajan, Shivashanmugam ^b   Chandra, Suresh ^b  

^a ROYAL VICTORIA INFIRMARY   (United Kingdom)

^b NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

Amnesia; Electroconvulsive shocks; Indomethacin; Memory; Nonsteroidal antiinflammatory drugs (NSAIDs); Rats

Indexed keywords

INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DRUG EFFECT; ELECTRIC SHOCK; LATENT PERIOD; LEARNING; MALE; MEMORY; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; RAT; RECALL; RETROGRADE AMNESIA; SEIZURE;

AMNESIA, RETROGRADE; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ELECTROSHOCK; INDOMETHACIN; MALE; MEMORY DISORDERS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0036570234     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(01)01219-7     Document Type: Article

References (15)

1. Inflammatory mechanisms in Alzheimer's disease: Implications for therapy
2. Herbal treatments for ECS-induced memory deficits: A review of research and a discussion on animal models
3. Regional distribution of arachidonic acid metabolites in rat brain following convulsive stimuli
4. Indomethacin and cognitivefunction in healthy elderly volunteers
5. Does ECT alter brain structure?
6. Herbal pharmacotherapy for the attenuation of ECS induced anterograde and retrograde amnestic deficits
7. Inhibitors of cyclooxegenases produce amnesia for passive avoidance task in the chick
8. Interactions of cholecystokinin, beta-endorphin, and their antagonists on passive avoidance behavior in rats
9. Pharmacological treatment of the cognitive side effects of ECT: A review
10. The clinical potential of cyclooxygenase-2-specific inhibitors
11. Electroconvulsive therapy and plasma prostaglandin E2 metabolite in major depressive disorder
12. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: A review of 17 epidemiologic studies
13. Clinical trial of indomethacin in Alzheimer's disease
14. A double-blind, placebo-controlled trial of diclofenac/misoprostol in Alzheimer's disease
15. Impaired neuropsychological performance in chronic non-malignant pain patients receiving long-term oral opioid therapy